Literature DB >> 2895776

Characterization of an outbreak of Clostridium perfringens food poisoning by quantitative fecal culture and fecal enterotoxin measurement.

G Birkhead1, R L Vogt, E M Heun, J T Snyder, B A McClane.   

Abstract

Published criteria for implicating Clostridium perfringens as the cause of food-poisoning outbreaks include finding a median fecal C. perfringens spore count of greater than 10(6)/g among specimens from ill persons. We investigated a food-poisoning outbreak with the epidemiologic characteristics of C. perfringens-related disease in a nursing home in which the median fecal spore count for ill patients (2.5 X 10(7)/g) was similar to that for well patients (4.0 X 10(6)/g), making the etiology of the outbreak uncertain. All ill and well patients tested had eaten turkey, the implicated food item. C. perfringens enterotoxin was detected by reverse passive latex agglutination in fecal specimens from six of six ill and none of four well patients who had eaten turkey (P = 0.005), suggesting that this organism had caused the outbreak. This investigation suggests that detection of fecal C. perfringens enterotoxin is a specific way to identify this organism as the causative agent in food-poisoning outbreaks.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895776      PMCID: PMC266315          DOI: 10.1128/jcm.26.3.471-474.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

Review 1.  Food poisoning due to Clostridium perfringens in the United States.

Authors:  W X Shandera; C O Tacket; P A Blake
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

2.  Rapid detection of Clostridium perfringens type A enterotoxin by enzyme-linked immunosorbent assay.

Authors:  B A McClane; R J Strouse
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

3.  An enzyme-linked immunosorbent assay for the detection of Clostridium perfringens enterotoxin antibody.

Authors:  L Niilo; H J Cho
Journal:  Can J Comp Med       Date:  1984-01

4.  Faecal carriage of Clostridium perfringens.

Authors:  M F Stringer; G N Watson; R J Gilbert; J G Wallace; J E Hassall; E I Tanner; P P Webber
Journal:  J Hyg (Lond)       Date:  1985-10

5.  Infant botulism: clinical spectrum and epidemiology.

Authors:  J A Thompson; L A Glasgow; J R Warpinski; C Olson
Journal:  Pediatrics       Date:  1980-12       Impact factor: 7.124

6.  Persistent high numbers of Clostridium perfringens in the intestines of Japanese aged adults.

Authors:  T Yamagishi; T Serikawa; R Morita; S Nakamura; S Nishida
Journal:  Jpn J Microbiol       Date:  1976-10

7.  Clostridium perfringens Type A Food Poisoning I. Response of the Rabbit Ileum as an Indication of Enteropathogenicity of Strains of Clostridium perfringens in Monkeys.

Authors:  C L Duncan; D H Strong
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

8.  Improved medium for sporulation of Clostridium perfringens.

Authors:  C L Duncan; D H Strong
Journal:  Appl Microbiol       Date:  1968-01

9.  Ileal loop fluid accumulation and production of diarrhea in rabbits by cell-free products of Clostridium perfringens.

Authors:  C L Duncan; D H Strong
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

10.  Enterotoxin synthesis by nonsporulating cultures of Clostridium perfringens.

Authors:  S B Goldner; M Solberg; S Jones; L S Post
Journal:  Appl Environ Microbiol       Date:  1986-09       Impact factor: 4.792

View more
  15 in total

1.  Evidence for antibiotic induced Clostridium perfringens diarrhoea.

Authors:  N Modi; M H Wilcox
Journal:  J Clin Pathol       Date:  2001-10       Impact factor: 3.411

2.  Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin.

Authors:  Ganes Chakrabarti; Xin Zhou; Bruce A McClane
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

3.  Clostridium perfringens enterotoxin damages the human intestine in vitro.

Authors:  M E Fernández Miyakawa; V Pistone Creydt; F A Uzal; B A McClane; C Ibarra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Development and application of a mouse intestinal loop model to study the in vivo action of Clostridium perfringens enterotoxin.

Authors:  Justin A Caserta; Susan L Robertson; Juliann Saputo; Archana Shrestha; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

Review 5.  Animal models to study the pathogenesis of enterotoxigenic Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane
Journal:  Microbes Infect       Date:  2012-06-17       Impact factor: 2.700

6.  Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with non-food-borne human gastrointestinal diseases.

Authors:  R E Collie; B A McClane
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

7.  Molecular epidemiology of Clostridium perfringens related to food-borne outbreaks of disease in Finland from 1984 to 1999.

Authors:  Susanna Lukinmaa; Elina Takkunen; Anja Siitonen
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792

8.  Detection of enterotoxigenic Clostridium perfringens in food and fecal samples with a duplex PCR and the slide latex agglutination test.

Authors:  P Fach; M R Popoff
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

9.  The rapid identification of Clostridium perfringens as the possible aetiology of a diarrhoeal outbreak using PCR.

Authors:  J P Loh; Y C Liu; S W Chew; E S Ong; J M Fam; Y Y Ng; M B Taylor; E E Ooi
Journal:  Epidemiol Infect       Date:  2007-10-26       Impact factor: 2.451

10.  Comparison of Western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens.

Authors:  J F Kokai-Kun; J G Songer; J R Czeczulin; F Chen; B A McClane
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.